Evidence map›Paper›PMID 31785145›Full record

ArticleAging2019

Ets2 suppresses inflammatory cytokines through MAPK/NF-κB signaling and directly binds to the IL-6 promoter in macrophages.

Xianwei Ma, Zhengyu Jiang, Na Li, Wei Jiang, Peng Gao, Mingjin Yang, Xiya Yu, Guifang Wang, Yan Zhang

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. AnGenes · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. ETS Transcription Factors in Immune Cells and Immune-Related Diseases.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Xianwei MaScientific Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Zhengyu JiangFaculty of Anesthesiology, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai 200433, China.
Na LiFaculty of Anesthesiology, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai 200433, China.
Wei JiangDepartment of Respiration, Second Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Peng GaoCancer Institute, Institute of Translational Medicine, Second Military Medical University/Naval Medical University, Shanghai 200433, China.
Mingjin YangNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University/Naval Medical University, Shanghai 200433, China.
Xiya YuFaculty of Anesthesiology, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai 200433, China.
Guifang WangDepartment of Respiratory Diseases, Huashan Hospital, Fudan University, Shanghai 200433, China.
Yan ZhangFaculty of Anesthesiology, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai 200433, China.
Second Military Medical University · CNChanghai Hospital · CNChinese PLA General Hospital · CNFudan University · CNShanghai Public Health Clinical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proper activation of Toll-like receptor (TLR)-mediated signaling and production of proinflammatory cytokines are critical for the initiation of innate immunity, while the specific mechanism maintaining inflammatory homeostasis remains mostly unknown. Here, we show that Ets2 is upregulated following LPS and VSV stimulation. Ets2 knockdown or knockout leads to increased IL-6, TNF-α, and IFN-β production in macrophages. Consistently, Ets2-deficient mice show exacerbated inflammatory cytokine production and are more susceptible to CLP-induced sepsis. Mechanistically, Ets2 inhibits the LPS- and VSV-induced activation of ERK1/2, JNK, p38, and p65. Ets2 also binds to the promoter of IL-6 to inhibit transcription. Collectively, the results of the present study show the negative regulatory role of Ets2 in LPS- and VSV-induced inflammation through the suppression of MAPK/NF-κB signaling, direct binding to the IL-6 promoter and inhibition of transcription.

Indexed as

AnimalsCytokinesExtracellular Signal-Regulated MAP KinasesImmunity, InnateInflammationInterleukin-6MacrophagesMiceMice, Inbred C57BLMice, KnockoutNF-kappa BPromoter Regions, GeneticProto-Oncogene Protein c-ets-2Signal TransductionCytokinesEts2 protein, mouseExtracellular Signal-Regulated MAP KinasesInterleukin-6NF-kappa BProto-Oncogene Protein c-ets-2Ets2IL-6macrophagepro-inflammatory cytokineToll-like receptor

Identifiers

PMID31785145
PMCPMC6914388
OpenAlexW2989865252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.